3
Announcements
Trials
Browse
Landscape
Status
Completed
14
Terminated
4
Recruiting
4
Unknown
2
Active not recruiting
1
Sponsor
Conditions
Breast Neoplasms
8
Neoplasm Metastasis
2
Advanced Breast Cancer
2
Prostatic Neoplasms
1
Melanoma
1
HER2-positive Breast Cancer
1
Exanthema
1
Diarrhea
1
Brest Cancer
1
Breast Cancer Metastatic
1
Advanced/Metastatic Solid Tumors
1
Interventions
Exercise
8
Standard of Care
5
trametinib
3
tislelizumab
3
Radiotherapy
3
Radiosurgery
3
Palliative Care
3
Paclitaxel
3
Gemcitabine
3
130-nm albumin-bound paclitaxel
3
trastuzumab deruxtecan
2
cemiplimab
2
Therapeutics
2
Surveys and Questionnaires
2
Resistance Training
2
Oxaliplatin
2
Nivolumab
2
Maintenance
2
Immune Checkpoint Inhibitors
2
Drug Therapy
2
Cisplatin
2
Carboplatin
2
vedolizumab
1
toripalimab
1
surufatinib
1
sparsentan
1
sintilimab
1
semaglutide
1
posaconazole
1
pomalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neoplasms
×
Fulvestrant
×
Clear all
No trials found.